收费全文 | 21263篇 |
免费 | 1971篇 |
国内免费 | 54篇 |
医药卫生 | 23288篇 |
2021年 | 419篇 |
2020年 | 248篇 |
2019年 | 429篇 |
2018年 | 516篇 |
2017年 | 375篇 |
2016年 | 398篇 |
2015年 | 425篇 |
2014年 | 618篇 |
2013年 | 866篇 |
2012年 | 1222篇 |
2011年 | 1292篇 |
2010年 | 766篇 |
2009年 | 696篇 |
2008年 | 1149篇 |
2007年 | 1143篇 |
2006年 | 1077篇 |
2005年 | 1135篇 |
2004年 | 1100篇 |
2003年 | 1051篇 |
2002年 | 949篇 |
2001年 | 452篇 |
2000年 | 446篇 |
1999年 | 412篇 |
1998年 | 249篇 |
1997年 | 231篇 |
1996年 | 170篇 |
1995年 | 160篇 |
1994年 | 134篇 |
1993年 | 152篇 |
1992年 | 279篇 |
1991年 | 272篇 |
1990年 | 293篇 |
1989年 | 257篇 |
1988年 | 228篇 |
1987年 | 188篇 |
1986年 | 247篇 |
1985年 | 207篇 |
1984年 | 186篇 |
1983年 | 185篇 |
1982年 | 142篇 |
1981年 | 139篇 |
1980年 | 143篇 |
1979年 | 169篇 |
1978年 | 152篇 |
1977年 | 149篇 |
1976年 | 123篇 |
1975年 | 142篇 |
1974年 | 150篇 |
1973年 | 147篇 |
1972年 | 115篇 |
Objectives
Despite evidence for increased musculoskeletal injury after concussion recovery, there is a lack of dynamic balance assessments that could inform management and research into this increased injury risk post-concussion. Our purpose was to identify tandem gait dynamic balance deficits in recreational athletes with a concussion history within the past 18-months compared to matched controls.Design
Cross-sectional, laboratory study.Methods
Fifteen participants with a concussion history (age: 19.7 ± 0.9 years; 9 females; median time since concussion 126 days, range 28–432 days), and 15 matched controls (19.7 ± 1.6 years; 9 females) with no recent concussion history participated. We measured center-of-pressure (COP) outcomes (velocity, path length, speed, dual-task cost) under 4 tandem gait conditions: (1) tandem gait, (2) tandem gait, eyes closed, (3) tandem gait, eyes open, cognitive distraction, and (4) tandem gait, eyes closed, cognitive distraction.Results
The concussion history group demonstrated slower tandem gait velocity compared to the control group (4.0 cm/s difference), thus velocity was used as a covariate when analyzing COP path length and speed. The concussion history group (23.5%) demonstrated greater COP speed dual-task cost than the control group (16.3%) during the eyes closed dual-task condition. No other comparisons were statistically significant.Conclusions
There may be subtle dynamic balance differences during tandem gait that are detectable after return-to-activity following concussion, but the clinical significance of these findings is unclear. Longitudinal investigations should identify acute movement deficits in varying visual and cognitive scenarios after concussion in comparison with recovery on traditional concussion assessment tools while also recording musculoskeletal injury outcomes. 相似文献Methods: A retrospective cohort design and data from two US healthcare claims repositories were employed. The study population included patients who had non-metastatic cancer of the breast, colon/rectum, lung or ovaries, or non-Hodgkin’s lymphoma (NHL), and who received myelosuppressive chemotherapy regimens with an intermediate/high risk for FN. For each patient, the first cycle of the first course was characterized in terms of PP-CSF use and FN episodes. Crude incidence proportions for PP-CSF and FN during the first cycle were estimated by calendar quarter (2010–2016); multivariable logistic regression models were used to estimate quarter-specific adjusted mean probabilities of FN by PP-CSF use.
Results: The study population totaled 142,730 patients with breast cancer (61%), colorectal cancer (14%), NHL (11%), ovarian cancer (10%) or lung cancer (5%). PP-CSF use increased from 52% in 1Q2010 to 58% in 4Q2016; pegfilgrastim was the most commonly used agent (>96% across quarters). PP-CSF administration on the same day as chemotherapy ranged from 8 to 11% until 1Q2015, and increased to 64% by 4Q2016. Adjusted incidence proportions for FN in the first chemotherapy cycle ranged from 2.7% (95% CI: 2.3–3.0) to 3.7% (95% CI: 3.1–4.3) among those who did not receive PP-CSF, and was 2.6% (95% CI: 2.5–2.7) across quarters among those who received PP-CSF.
Conclusions: Although the use of PP-CSF is commonplace in current US clinical practice, underutilization in cancer patients receiving chemotherapy regimens with an intermediate/high risk for FN may still be an issue. Use of same-day PP-CSF increased markedly from the end of 2015, although this finding reflects (at least in part) increased uptake of pegfilgrastim delivered via an on-body injector as well as the recent change in clinical practice guidelines. Overall, patients receiving PP-CSF appear to have a lower risk of FN during the first cycle of chemotherapy. 相似文献